DFC To Work With Indian Manufacturer Biological E Ltd. To Produce at Least 1 Billion Doses of COVID-19 Vaccines by End of 2022
U.S. International Development Finance Corporation to work with Indian manufacturer Biological E Ltd. to finance increased capacity to support its effort to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022.
U.S. International Development Finance Corporation to work with Indian manufacturer Biological E Ltd. to finance increased capacity to support its effort to produce at least 1 billion doses of COVID-19 vaccines by the end of 2022.
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)